Company Financials

SciClone Pharmaceuticals Financials

Hong Kong dollar

business SciClone Pharmaceuticals Company Profile

Main Stock Listing

HKEX: 6600

Market Capitalization HK$20.44 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 484.21
Forward PE 10.29
Price to Sales TTM HK$27.96
Price to Book MRQ HK$5.68
Enterprise to Revenue 24.43
Enterprise to EBITDA 539.65

Financial Reports as of Dec. 31, 2020

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2020-12-31
Profit Margin 5.26%
Operating Margin 4.53%
Return on Assets TTM -0.68%
Return on Equity TTM -1.56%

Income Statement

Revenue TTM HK$813,076,431
Revenue per Share TTM HK$5.22
Quarterly Revenue Growth 44.10%
Gross Profit TTM HK$435,353,513
EBITDA HK$23,846,411
Net Income to Common TTM HK$42,777,870
Diluted EPS TTM HK$0.19
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ HK$222,409,343
Total Cash per Share MRQ HK$0.90
Total Debt MRQ HK$
Total Debt to Equity MRQ 49.41
Current Ratio MRQ 2.01
Book Value per Share MRQ HK$16.19

Cash Flow

Operating Cash Flow TTM HK$34,130,002
Levered Free Cash Flow TTM HK$-3,418,226

6600 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 222,222,300
Float Shares 55,837,797
Avg 10 Volume 613,885
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders %
% Held by Institutions %

Stock Price Summary

Beta
Fifty Two Week Low HK$73.80
Fifty Two Week High HK$93.25
Fifty Two Week Change 19.73%
Day 50 MA HK$77.23
Day 200 MA HK$77.23

Dividends and Splits

Forward Annual Dividend Rate HK$1.56
Forward Annual Dividend Yield 1.70%
Trailing Annual Dividend Rate HK$0.39
Trailing Annual Dividend Yield 0.42%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2023-06-02
Last Split Factor
Last Split Date